Abstract Details
|
Jouko I. Isojarvi, MD, PhD
(Lundbeck)
PRESENTER |
No disclosure on file |
| Deborah A. Lee, MD, PhD (AlaWai Neurology Consulting LLC) | No disclosure on file |
| Vivienne Shen | Vivienne Shen has received personal compensation for serving as an employee of Lundbeck. |
| Jeffrey R. Buchhalter, MD, FÂé¶¹´«Ã½Ó³» (Buchhalter Consulting PLLC) | Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Buchhalter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. |
| Brian D. Moseley, MD | Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB. |